Back to search

Article

Detection of Emerging Ibrutinib Resistance by Flow Cytometry in Patients with Chronic Lymphocytic Leukaemia

2022-09-26

Abstract excerpt

<title>Abstract</title> <p>Background: Although ibrutinib is effective drug in the treatment of chronic lymphocytic leukaemia (CLL), during the treatment acquired resistance may occur, making its detection an important issue. We aimed to find phenotypic markers on CLL cells which expression may correlate with the appearance of ibrutinib resistance. <h4>Methods:</h4> We examined 28 (treatment naïve, ibrutinib sens...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dfc5615b-798f-52e7-b060-2938062eccfa
DOI
10.21203/rs.3.rs-1554274/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Detection of Emerging Ibrutinib Resistance by Flow Cytometry in Patients with Chronic Lymphocytic LeukaemiaDOI 10.21203/rs.3.rs-1554274/v1
Detection of Emerging Ibrutinib Resistance by Flow Cytometry in Patients with Chronic Lymphocytic LeukemiaSemantic proximity
Ibrutinib in Chronic Lymphocytic Leukemia: Clinical Applications, Drug Resistance, and ProspectsSemantic proximity
Resistance-Associated Mutations in Chronic Lymphocytic Leukemia Patients Treated With Novel AgentsSemantic proximity
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition.Semantic proximity
Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in Preclinical ModelsSemantic proximity
Patterns of resistance to B cell-receptor pathway antagonists in chronic lymphocytic leukemia and strategies for management.Semantic proximity
Deciphering Ibrutinib Resistance in Chronic Lymphocytic Leukemia.Semantic proximity
Are BTK and PLCG2 mutations necessary and sufficient for ibrutinib resistance in chronic lymphocytic leukemia?Semantic proximity
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemiaSemantic proximity
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinibSemantic proximity
Dissection of subclonal evolution by temporal mutation profiling in chronic lymphocytic leukemia patients treated with ibrutinibSemantic proximity
Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell MalignanciesSemantic proximity
Select a neighboring publication to make it the new centre.